"The French drug maker Sanofi said Thursday that its profit was slashed in the first quarter from a year earlier as falling sales and patent losses on key drugs combined to hammer earnings. Net profit was $1.3 billion, down 45 percent from a year earlier."
Related: A New Golden Age For Corporate Profits
